Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Interuniversity Institute for Biostatistics and statistical Bioinformatics (I-BIOSTAT), University of Hasselt, Agoralaan building D, 3590 Diepenbeek, Hasselt, Belgium.
Implement Sci. 2018 Jan 10;13(1):6. doi: 10.1186/s13012-017-0703-8.
In Belgium, the debate about the effect of the national academic detailing service (ADS) on prescribing quality in general practice is ongoing. In order to evaluate both the implementation strategies of the ADS and its effectiveness on appropriate prescribing of pain relief medication, we conducted a real-world cluster randomized controlled trial (cRCT).
In a pragmatic cRCT, all Belgian general practices previously visited by Farmaka were assessed for eligibility and randomized. Only practices randomized to the intervention group were invited for an academic detailing visit on appropriate prescribing of pain relief medication. GPs were unaware of the study, ensuring the production of real-world evidence but were given the option to opt out from the analysis. An objective outcome assessment was obtained using routinely collected reimbursement data. Primary outcomes were the proportion of patients reimbursed for an analgesic or NSAID, the defined daily dose of paracetamol per patient per month, the proportion of patients reimbursed for a recommended NSAID among those reimbursed for any NSAID and the proportion of patients reimbursed for both an NSAID and a proton pump inhibitor among those reimbursed for an NSAID. The impact of practice, GP and academic detailer characteristics were also assessed.
Three thousand five hundred twenty-nine general practices (4530 GPs) were eligible and randomized. One thousand six hundred ninety-eight practices (2171 GPs) in the intervention group and one thousand seven hundred three (2163 GPs) in the control group were included in the analysis. The intervention had a significant impact on the proportion of patients reimbursed for a recommended NSAID among those reimbursed for any NSAID (increase in odds (95% CI): 19% (10-29%)). A clear impact on other outcomes could not be detected. Additionally, we showed that the characteristics of the academic detailers might impact the effectiveness of the visit.
National implementation of academic detailing in Belgian general practices provided by Farmaka significantly improved the proportion of recommended NSAIDs prescribed by GPs, but not other outcomes related to appropriate prescribing of pain relief medication.
NCT01761864 . Registered 2 January 2013.
在比利时,关于国家学术详述服务(ADS)对一般实践中处方质量的影响的争论仍在继续。为了评估 ADS 的实施策略及其在缓解疼痛药物合理处方方面的有效性,我们进行了一项真实世界的集群随机对照试验(cRCT)。
在一项实用的 cRCT 中,对所有先前接受 Farmaka 访问的比利时一般实践进行了资格评估和随机分组。只有被随机分配到干预组的实践才被邀请参加关于缓解疼痛药物合理处方的学术详述访问。全科医生不知道这项研究,这确保了真实世界证据的产生,但他们可以选择不参与分析。使用常规收集的报销数据进行客观的结果评估。主要结果是接受镇痛剂或 NSAID 报销的患者比例、每位患者每月的扑热息痛定义日剂量、在接受任何 NSAID 报销的患者中,推荐 NSAID 的报销比例以及在接受 NSAID 报销的患者中,同时接受 NSAID 和质子泵抑制剂报销的比例。还评估了实践、全科医生和学术详述者特征的影响。
有 3529 家一般实践(4530 名全科医生)符合条件并进行了随机分组。1698 家实践(2171 名全科医生)被分配到干预组,1730 家实践(2163 名全科医生)被分配到对照组。干预措施对接受任何 NSAID 报销的患者中推荐 NSAID 的报销比例有显著影响(增加的优势比(95%CI):19%(10-29%))。不能检测到对其他结果的明显影响。此外,我们还表明,学术详述者的特征可能会影响访问的效果。
Farmaka 在比利时一般实践中实施的国家学术详述显著提高了全科医生开具推荐 NSAID 的比例,但对缓解疼痛药物合理处方的其他结果没有影响。
NCT01761864。2013 年 1 月 2 日注册。